Form 4: LifeStance Health Group Director Bessler Reports Acquisition of Restricted Stock Units
SEC Form 4
Director Robert Bessler reports acquisition of 36,363 restricted stock units in LifeStance Health Group.
Summary
- Robert Bessler, a director of LifeStance Health Group, reported acquiring 36,363 restricted stock units (RSUs) on July 21, 2024.
- Each RSU represents a contingent right to receive one share of LifeStance Health Group's common stock.
- Bessler also indirectly owns 36,363 shares through Alpine Glow Capital, 1,461,947 shares through the Vitthal Gift Trust, and 1,578,747 shares through the Shama Gift Trust.
- Bessler disclaims beneficial ownership of shares held by Alpine Glow Capital, Vitthal Gift Trust and Shama Gift Trust except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, so the sentiment is neutral. It simply reports a transaction.
Positives
- The acquisition of RSUs by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates insider confidence.
Key Dates
| Date | Description |
|---|---|
| 07/21/2024 | Date of transaction: Acquisition of 36,363 restricted stock units. |
| 08/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.